Cytokine (TNF alpha) blocking for acute and chronic graft versus host disease (GVHD)
Not Applicable
- Conditions
- Graft versus host disease (GVHD)
- Registration Number
- JPRN-UMIN000003147
- Lead Sponsor
- Yokohama city university hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 3
Inclusion Criteria
Not provided
Exclusion Criteria
1. sepsis, risk of sepsis 2. severe infection 3. active tuberculosis 4. anaphylactic episode of etanercept 5. demyelinating disease 6. congestive heart failure
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Evaluation of clinical GVHD score and improvement of labolatory data between before with after therapy.
- Secondary Outcome Measures
Name Time Method